VREX — Varex Imaging Corp
NASDAQ · Healthcare · Medical Devices
$18.47
-$0.02 (-0.11%)
Varex Imaging Corp (VREX) is a medical devices company listed on NASDAQ. It is led by Sunny S. Sanyal, based in 1678 S. Pioneer Road, Salt Lake City, UT, United States, 84104, with about 2,300 employees. Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. The company sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. It has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. The company was incorporated in 2016 and is headquartered in Salt Lake City, Utah.
Latest reported VREX revenue for 2025-10-03 was $844.6M. Net income was -$69.9M. Revenue was up 316.1% from 2025-07-04 to 2025-10-03. VREX currently screens at market cap $350.0M.
Use this VREX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the VREX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the VREX SEC filings page. Lician reads the product cache first so this HTML stays unique to Varex Imaging Corp even when a live quote feed is slow.
About Varex Imaging Corp
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. The company sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. It has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. The company was incorporated in 2016 and is headquartered in Salt Lake City, Utah.
VREX Key Statistics
Market Cap
$349.95M
Volume
552,754
Previous Close
$18.50
Day Range
$18.45 – $18.53
EPS
-$1.70
Revenue
$844.60M
Net Income
-$69.90M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+4.1%
Profit Margin
-8.3%
Employees
2,300
VREX Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $844.60M | $811.00M | $893.40M | $859.40M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$69.90M | -$48.30M | $47.90M | $30.80M |
| EPS (Diluted) | -$1.70 | -$1.20 | $1.07 | $0.73 |
Total Assets
$1.11B
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$145.00M
Operating Cash Flow
$41.70M
Free Cash Flow
$0.00
Varex Imaging Corp Company Information
- President, CEO & Director
- Sunny S. Sanyal
- Headquarters
- 1678 S. Pioneer Road, Salt Lake City, UT, United States, 84104
- Website
- www.vareximaging.com
- Phone
- 801 972 5000
- IPO / Founded
- 2017-01-20
- Sector
- Healthcare
- Industry
- Medical Devices